Skip to content
healthcare.dev

Erlotinib

NDC 68382-914, Erlotinib, tablet, from Zydus Pharmaceuticals USA Inc..

Product NDC
68382-914
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213065
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68382-914 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERLOTINIB HYDROCHLORIDE100 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
68382-914-066838209140630 TABLET in 1 BOTTLE (68382-914-06)
68382-914-166838209141690 TABLET in 1 BOTTLE (68382-914-16)
68382-914-84683820914843 BLISTER PACK in 1 CARTON (68382-914-84) / 10 TABLET in 1 BLISTER PACK (68382-914-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c35e019d-ec34-4e61-9400-a7ae7913e025

Use it

Look up 68382-914 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68382-914 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68382-914. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.